BAY 59-8862
Drug timelines are a Plus or Pro feature.
6 regulatory and trial events tracked for BAY 59-8862, covering 2008-07-24 to 2022-09-26. Get the full timeline:
Most recent: Clinical Trial Update: BAY 59-8862 in Treating Patients With Non-Small Cell Lung Cancer [Phase 2]